MAPT and dementia: The overarching aim of this study was to perform a head-to-head comparison between plasma pTau181 and tau PET in a cohort of participants with subjective cognitive decline (SCD) and MCI or dementia due to AD (MCI/AD) against several clinically relevant measures.